Clinical leishmaniasis in dogs living in the UK

P. Silvestrini*, D. Batchelor, K. Allenspach, C. Maunder, M. Seth, A. Mas, T. Hill, G. Serrano, X. Roura, M. Planellas, A. J. German, J. Pastor

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

5 Citations (Scopus)
338 Downloads (Pure)


Objective: To investigate the prevalence of leishmaniasis in a canine population in the UK and to describe clinical presentation, clinicopathological abnormalities, therapeutic protocols and outcome in this non-endemic country.

Materials and Methods:
Medical records of dogs diagnosed with leishmaniasis at referral centres in the UK were retrospectively reviewed.

Results: The prevalence was between 0.007 and 0.04% with a higher number of cases in southern England. All dogs had a history of travel to or from an endemic country. Lethargy, dermatological signs, decreased appetite and lameness were the most common reasons for presentation. Allopurinol was used alone in the majority of cases.

Clinical significance: Although rare, CanL in the UK should be considered in patients showing compatible clinical signs and with a history of travel to or from endemic areas.
Original languageEnglish
Pages (from-to)453–458
Number of pages6
JournalJournal of Small Animal Practice
Issue number9
Early online date1 Jun 2016
Publication statusPublished - Sep 2016


  • Canine
  • Infectious Disease
  • Leishmania
  • UK


Dive into the research topics of 'Clinical leishmaniasis in dogs living in the UK'. Together they form a unique fingerprint.

Cite this